{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:02:05Z","timestamp":1785528125113,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303132"],"award-info":[{"award-number":["82303132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82374090"],"award-info":[{"award-number":["82374090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Hebei Natural Science Foundation","award":["H2021206419"],"award-info":[{"award-number":["H2021206419"]}]},{"name":"the Hebei Provincial Government-funded Clinical Talent Project","award":["ZF2025178"],"award-info":[{"award-number":["ZF2025178"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02691-w","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:35:50Z","timestamp":1779942950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircSPARC promotes esophageal squamous cell carcinoma through an HNRNPC\u2013EPN2 splicing axis that activates Wnt\/\u03b2-Catenin signaling"],"prefix":"10.1186","volume":"25","author":[{"given":"Suli","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"3","key":"2691_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2691_CR2","doi-asserted-by":"crossref","unstructured":"Deboever N, Jones CM, Yamashita K, Ajani J, Hofstetter WL. Advances in diagnosis and management of cancer of the esophagus. BMJ. 2024;385 (e074962).","DOI":"10.1136\/bmj-2023-074962"},{"issue":"1","key":"2691_CR3","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41467-023-37440-w","volume":"14","author":"L Li","year":"2023","unstructured":"Li L, Jiang D, Zhang Q, Liu H, Xu F, Guo C, Qin Z, Wang H, Feng J, Liu Y, et al. Integrative proteogenomic characterization of early esophageal cancer. Nat Commun. 2023;14(1):1666.","journal-title":"Nat Commun"},{"issue":"1","key":"2691_CR4","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1038\/s41467-020-17227-z","volume":"11","author":"W Cao","year":"2020","unstructured":"Cao W, Lee H, Wu W, Zaman A, McCorkle S, Yan M, Chen J, Xing Q, Sinnott-Armstrong N, Xu H, et al. Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma. Nat Commun. 2020;11(1):3675.","journal-title":"Nat Commun"},{"issue":"1","key":"2691_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","volume":"24","author":"X Wu","year":"2025","unstructured":"Wu X, Que H, Li Q, Wei X. Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. Mol Cancer. 2025;24(1):171.","journal-title":"Mol Cancer"},{"issue":"29","key":"2691_CR6","doi-asserted-by":"publisher","first-page":"e03223","DOI":"10.1002\/advs.202503223","volume":"12","author":"SJ Li","year":"2025","unstructured":"Li SJ, Liang ZR, Liu ZC, Luo XP, Li JY, Yu XM, Huang XZ, He Y, Xu TY, Xu JJ, et al. LIMK1 as a Novel Kinase of \u03b2-Catenin Promotes Esophageal Cancer Metastasis by Cooperating with CDK5. Adv Sci (Weinh). 2025;12(29):e03223.","journal-title":"Adv Sci (Weinh)"},{"issue":"22","key":"2691_CR7","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1158\/0008-5472.CAN-23-2241","volume":"84","author":"L Zhou","year":"2024","unstructured":"Zhou L, Tian J, Wang K, Ma Y, Chen X, Luo H, Lu B, Wang N, Wang P, Liu X, et al. Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma. Cancer Res. 2024;84(22):3894\u2013908.","journal-title":"Cancer Res"},{"issue":"1","key":"2691_CR8","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1038\/s41467-021-23501-5","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, Shao F, Yang X, Wang J, Zhu R, Yang Y, Zhao G, Guo D, Sun Y, Wang J, et al. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N (6)-methyladenosine-dependent YTHDF binding. Nat Commun. 2021;12(1):3803.","journal-title":"Nat Commun"},{"issue":"9","key":"2691_CR9","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41589-025-01870-y","volume":"21","author":"A Sharma","year":"2025","unstructured":"Sharma A, Zalejski J, Bendre SV, Kavrokova S, Hasdemir HS, Ozgulbas DG, Sun J, Pathmasiri KC, Shi R, Aloulou A, et al. Cholesterol-targeting Wnt-\u03b2-catenin signaling inhibitors for colorectal cancer. Nat Chem Biol. 2025;21(9):1376\u201386.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2691_CR10","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1038\/s41467-025-59871-3","volume":"16","author":"K Wong","year":"2025","unstructured":"Wong K, Bishop JA, Weinreb I, Motta M, Del Castillo Velasco-Herrera M, Bellacchio E, Ferreira I, van der Weyden L, Boccacino JM, Lauri A, et al. Wnt\/\u03b2-catenin activation by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary basal cell adenoma. Nat Commun. 2025;16(1):4657.","journal-title":"Nat Commun"},{"issue":"1","key":"2691_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","volume":"21","author":"JM Bugter","year":"2021","unstructured":"Bugter JM, Fenderico NM, Maurice MM. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer. 2021;21(1):5\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2691_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-022-00545-z","volume":"24","author":"L Marasco","year":"2023","unstructured":"Marasco L, EKornblihtt AR. The physiology of alternative splicing. Nat Rev Mol Cell Biol. 2023;24(4):242\u201354.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"2691_CR13","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.7150\/ijbs.46751","volume":"16","author":"X Zheng","year":"2020","unstructured":"Zheng X, Peng Q, Wang L, Zhang X, Huang L. Wang JQin Z. Serine\/ arginine-rich splicing factors: the bridge linking alternative splicing and cancer. Int J Biol Sci. 2020;16(13):2442\u201353.","journal-title":"Int J Biol Sci"},{"issue":"21","key":"2691_CR14","doi-asserted-by":"publisher","first-page":"12270","DOI":"10.1093\/nar\/gkx831","volume":"45","author":"I Passacantilli","year":"2017","unstructured":"Passacantilli I, Frisone P, De Paola E, Fidaleo M, Paronetto M. hnRNPM guides an alternative splicing program in response to inhibition of the PI3K\/AKT\/mTOR pathway in Ewing sarcoma cells. Nucleic Acids Res. 2017;45(21):12270\u201384.","journal-title":"Nucleic Acids Res"},{"key":"2691_CR15","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhang P, Xiong Z, Lan Y, Guo H, Wu R, Li C, Fan H, Du Y, Zhu X et al. Snord15b Maintains Stemness of Intestinal Stem Cells via Enhancement of Alternative Splicing of Btrc Short Isoform for Suppression of \u03b2-Catenin Ubiquitination. Adv Sci (Weinh). 2025; e04485.","DOI":"10.1002\/advs.202504485"},{"issue":"8","key":"2691_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41419-024-06954-6","volume":"15","author":"N Mohan","year":"2024","unstructured":"Mohan N, Johnson GS, Tovar Perez JE, Dashwood WM. Rajendran PDashwood R H. Alternative splicing of BAZ1A in colorectal cancer disrupts the DNA damage response and increases chemosensitization. Cell Death Dis. 2024;15(8):570.","journal-title":"Cell Death Dis"},{"key":"2691_CR17","doi-asserted-by":"publisher","first-page":"ncomms11840","DOI":"10.1038\/ncomms11840","volume":"7","author":"Y Qi","year":"2016","unstructured":"Qi Y, Yu J, Han W, Fan X, Qian H, Wei H, Tsai YH, Zhao J, Zhang W, Liu Q, et al. A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation. Nat Commun. 2016;7:ncomms11840.","journal-title":"Nat Commun"},{"issue":"24","key":"2691_CR18","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1038\/s41388-021-01849-8","volume":"40","author":"Q Wu","year":"2021","unstructured":"Wu Q, Zhang Y, An H, Sun W, Wang R, Liu M, Zhang K. The landscape and biological relevance of aberrant alternative splicing events in esophageal squamous cell carcinoma. Oncogene. 2021;40(24):4184\u201397.","journal-title":"Oncogene"},{"issue":"1","key":"2691_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13578-021-00546-z","volume":"11","author":"J Ding","year":"2021","unstructured":"Ding J, Li C, Cheng Y, Du Z, Wang Q, Tang Z, Song C, Xia Q, Bai W, Lin L, et al. Alterations of RNA splicing patterns in esophagus squamous cell carcinoma. Cell Biosci. 2021;11(1):36.","journal-title":"Cell Biosci"},{"issue":"3","key":"2691_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager HKjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"2691_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2691_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2691_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-023-01912-w","volume":"23","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zeng X, Zhu Y, Leng M, Zhang Z, Wang Q, Liu X, Zeng S, Xiao Y, Hu C, et al. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p\/CYP1B1 axis. Mol Cancer. 2024;23(1):4.","journal-title":"Mol Cancer"},{"issue":"33","key":"2691_CR24","doi-asserted-by":"publisher","first-page":"e2012881118","DOI":"10.1073\/pnas.2012881118","volume":"118","author":"X Wang","year":"2021","unstructured":"Wang X, Li J, Bian X, Wu C, Hua J, Chang S, Yu T, Li H, Li Y, Hu S, et al. CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer. Proc Natl Acad Sci U S A. 2021;118(33):e2012881118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2691_CR25","doi-asserted-by":"publisher","first-page":"102493","DOI":"10.1016\/j.redox.2022.102493","volume":"57","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen S, Wei S, Cheng S, Shi R, Zhao R, Zhang W, Zhang Q, Hua T, Feng D, et al. CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biol. 2022;57:102493.","journal-title":"Redox Biol"},{"issue":"1","key":"2691_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13046-022-02299-0","volume":"41","author":"D Chen","year":"2022","unstructured":"Chen D, Zhou H, Cai Z, Cai K, Liu J, Wang W, Miao H, Li H, Li R, Li X, et al. CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling. J Exp Clin Cancer Res. 2022;41(1):120.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2691_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13046-023-02723-z","volume":"42","author":"Z Ma","year":"2023","unstructured":"Ma Z, Chen H, Xia Z, You J, Han C, Wang S, Xia W, Bai Y, Liu T, Xu L, et al. Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing. J Exp Clin Cancer Res. 2023;42(1):169.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2691_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/carcin\/bgad050","volume":"44","author":"S Dai","year":"2023","unstructured":"Dai S, Zhang C, Wei X, Wang X, Wen Y, Gao F, Zhao L, Shan B. RNA sequencing reveals the implication of the circRNA-associated ceRNA network in oesophageal squamous cell carcinoma. Carcinogenesis. 2023;44(7):596\u2013609.","journal-title":"Carcinogenesis"},{"issue":"7540","key":"2691_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu N, Dai Q, Zheng G, He C. Parisien MPan T. N (6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 2015;518(7540):560\u20134.","journal-title":"Nature"},{"issue":"12","key":"2691_CR30","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1172\/JCI64537","volume":"122","author":"S Pasula","year":"2012","unstructured":"Pasula S, Cai X, Dong Y, Messa M, McManus J, Chang B, Liu X, Zhu H, Mansat RS, Yoon SJ, et al. Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. J Clin Invest. 2012;122(12):4424\u201338.","journal-title":"J Clin Invest"},{"issue":"1","key":"2691_CR31","doi-asserted-by":"publisher","first-page":"e129374","DOI":"10.1172\/JCI129374","volume":"131","author":"K Song","year":"2021","unstructured":"Song K, Cai X, Dong Y, Wu H, Wei Y, Shankavaram UT, Cui K, Lee Y, Zhu B, Bhattacharjee S, et al. Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. J Clin Invest. 2021;131(1):e129374.","journal-title":"J Clin Invest"},{"issue":"5","key":"2691_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm.2017.132","volume":"19","author":"A Kaksonen MRoux","year":"2018","unstructured":"Kaksonen MRoux A. Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2018;19(5):313\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5506","key":"2691_CR33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.291.5506.1047","volume":"291","author":"T Itoh","year":"2001","unstructured":"Itoh T, Koshiba S, Kigawa T, Kikuchi A, Yokoyama S, Takeda T. Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. Science. 2001;291(5506):1047\u201351.","journal-title":"Science"},{"issue":"1","key":"2691_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.devcel.2008.04.015","volume":"15","author":"H Yamamoto","year":"2008","unstructured":"Yamamoto H, Sakane H, Yamamoto H, Michiue TKikuchi A. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling. Dev Cell. 2008;15(1):37\u201348.","journal-title":"Dev Cell"},{"issue":"10","key":"2691_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/emboj.2012.83","volume":"31","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, He XHowe PH. Disabled-2 (Dab2) inhibits Wnt\/\u03b2-catenin signalling by binding LRP6 and promoting its internalization through clathrin. Embo j. 2012;31(10):2336\u201349.","journal-title":"Embo j"},{"issue":"8051","key":"2691_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","volume":"638","author":"D Zhang","year":"2025","unstructured":"Zhang D, Duque-Jimenez J, Facchinetti F, Brixi G, Rhee K, Feng WW, J\u00e4nne PA, Zhou X. Transferrin receptor targeting chimeras for membrane protein degradation. Nature. 2025;638(8051):787\u201395.","journal-title":"Nature"},{"issue":"34","key":"2691_CR37","doi-asserted-by":"publisher","first-page":"e2304895","DOI":"10.1002\/advs.202304895","volume":"10","author":"Z Wu","year":"2023","unstructured":"Wu Z, Zuo X, Zhang W, Li Y, Gui R, Leng J, Shen H, Pan B, Fan L, Li J, et al. m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia. Adv Sci (Weinh). 2023;10(34):e2304895.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"2691_CR38","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/neuonc\/noaf019","volume":"27","author":"X Zhang","year":"2025","unstructured":"Zhang X, Jiang M, Niu W, Xu B, Zhang C, Yang M. Hu SNiu C. CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling. Neuro Oncol. 2025;27(8):1987\u20132005.","journal-title":"Neuro Oncol"},{"issue":"1","key":"2691_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02122-8","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang T, Li Q, Zheng Z, Liao L, Cen J, Chen W, Luo J, Xu Y, Zhou M, et al. circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4. Mol Cancer. 2025;24(1):1.","journal-title":"Mol Cancer"},{"issue":"2","key":"2691_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm1571","volume":"6","author":"CW Le Roy","year":"2005","unstructured":"Le Roy CW. Clathrin- and non-clathrin-mediated endocytic regulatioon of cell signalling. Nat Rev Mol Cell Biol. 2005;6(2):112\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2691_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","volume":"23","author":"B Banushi","year":"2023","unstructured":"Banushi B, Joseph SR, Lum B, Lee JJSimpson F. Endocytosis in cancer and cancer therapy. Nat Rev Cancer. 2023;23(7):450\u201373.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2691_CR42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrm970","volume":"3","author":"B Wendland","year":"2002","unstructured":"Wendland B. Epsins: adaptors in endocytosis? Nat Rev Mol Cell Biol. 2002;3(12):971\u20137.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6695","key":"2691_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/29555","volume":"394","author":"H Chen","year":"1998","unstructured":"Chen H, Fre S, Slepnev VI, Capua MR, Takei K, Butler MH, Di Fiore PP, De Camilli P. Epsin is an EH-domain-binding protein implicated in clathrin- mediated endocytosis. Nature. 1998;394(6695):793\u20137.","journal-title":"Nature"},{"issue":"8","key":"2691_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.122.063075","volume":"147","author":"Y Dong","year":"2023","unstructured":"Dong Y, Wang B, Du M, Zhu B, Cui K, Li K, Yuan K, Cowan DB, Bhattacharjee S, Wong S, et al. Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-\u03b2 Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis. Circulation. 2023;147(8):669\u201385.","journal-title":"Circulation"},{"issue":"2","key":"2691_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.devcel.2006.07.003","volume":"11","author":"H Yamamoto","year":"2006","unstructured":"Yamamoto H, Komekado HKikuchi A. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. Dev Cell. 2006;11(2):213\u201323.","journal-title":"Dev Cell"},{"key":"2691_CR46","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1038\/ncomms7380","volume":"6","author":"B Chang","year":"2015","unstructured":"Chang B, Tessneer KL, McManus J, Liu X, Hahn S, Pasula S, Wu H, Song H, Chen Y, Cai X, et al. Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development. Nat Commun. 2015;6:6380.","journal-title":"Nat Commun"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02691-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02691-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:18:39Z","timestamp":1785521919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02691-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02691-w","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University (approval numbers EC112 and KY021), and written informed consent was obtained from all patients prior to their participation. All animal experiments were approved by the Animal Ethics Committee of the Fourth Hospital of Hebei Medical University (approval no. 2023030) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals by the International Committee. Every effort was made to minimize the numbers and suffering of the included animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed the final version of the manuscript and approve it for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"183"}}